BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31918382)

  • 1. Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.
    Guo Z; Chen X; Tan Y; Xu Z; Xu L
    Blood Cells Mol Dis; 2020 Mar; 81():102393. PubMed ID: 31918382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.
    Uchiumi H; Matsushima T; Yamane A; Doki N; Irisawa H; Saitoh T; Sakura T; Jimbo T; Handa H; Tsukamoto N; Karasawa M; Miyawaki S; Murakami H; Nojima Y
    Int J Hematol; 2007 Aug; 86(2):137-42. PubMed ID: 17875527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.
    Arana Rosainz MJ; Nguyen N; Wahed A; Lelenwa LC; Aakash N; Schaefer K; Rios A; Kanaan Z; Chen L
    Int J Lab Hematol; 2021 Apr; 43(2):218-226. PubMed ID: 33099879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
    Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Disseminated Intravascular Coagulation in Acute Leukemias.
    Ten Cate H; Leader A
    Hamostaseologie; 2021 Apr; 41(2):120-126. PubMed ID: 33860520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M; Gürsoy V; Hunutlu FC; Erkan B; Demirci U; Bas V; Gulsaran SK; Pinar IE; Ersal T; Kirkizlar TA; Atli EI; Kirkizlar HO; Ümit EG; Gürkan H; Ozkocaman V; Ozkalemkas F; Demir AM; Ali R
    Ann Hematol; 2022 May; 101(5):1049-1057. PubMed ID: 35190843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
    Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
    Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
    Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
    Paterno G; Palmieri R; Tesei C; Nunzi A; Ranucci G; Mallegni F; Moretti F; Meddi E; Tiravanti I; Marinoni M; Page C; Fagiolo S; Buzzatti E; Secchi R; Gurnari C; Maurillo L; Buccisano F; Venditti A; Del Principe MI
    Thromb Res; 2024 Apr; 236():30-36. PubMed ID: 38387301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S; Ge Y; Li Z; Yang T
    Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulant and fibrinolytic activities in the leukemic cell lysates.
    Wada H; Nagano T; Tomeoku M; Kuto M; Karitani Y; Deguchi K; Shirakawa S
    Thromb Res; 1983 May; 30(4):315-22. PubMed ID: 6351339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
    Yokoyama H; Takahashi N; Katsuoka Y; Inomata M; Ito T; Meguro K; Kameoka Y; Tsumanuma R; Murai K; Noji H; Ishizawa K; Ito S; Onishi Y; Harigae H;
    Int J Hematol; 2017 May; 105(5):606-613. PubMed ID: 28176226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the International Society on Thrombosis and Haemostasis Scoring System in Evaluation of Disseminated Intravascular Coagulation in Patients with Acute Leukemias.
    Aggarwal A; Mahajan D; Sharma P
    South Asian J Cancer; 2021 Dec; 10(4):241-245. PubMed ID: 34984203
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation.
    Lee HJ; Park HJ; Kim HW; Park SG
    Blood Res; 2013 Dec; 48(4):250-3. PubMed ID: 24466548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
    Infante JB; Esteves GV; Raposo J; de Lacerda JF
    Eur J Haematol; 2024 May; 112(5):840-844. PubMed ID: 38305491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
    Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
    Sarris A; Cortes J; Kantarjian H; Pierce S; Smith T; Keating M; Koller C; Kornblau S; O'Brien S; Andreeff M
    Leuk Lymphoma; 1996 Mar; 21(1-2):85-92. PubMed ID: 8907274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.